Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 21, 2016

View Archived Issues

Allakos completes dosing in phase I trial of AK-001

FDA grants orphan drug designation to Thetis Pharmaceuticals' TP-252

Mifepristone granted .U.S orphan designation for ovarian cancer

Amarantus and Avant Diagnostics enter a letter of intent to merge diagnostics business unit

Primate models of retinal degeneration allow assessment of retinal transplantation

Glenmark updates pipeline data

Coprimary efficacy endpoints met in phase III trial of beloranib for Prader-Willi syndrome

Transgenomic launches new MX-ICP cancer panels

Novozymes forms an independent company to separate its biopharma activities

FDA approves sBLA for Arzerra as extended treatment of recurrent or progressive CLL

Enrollment open in phase I/II study of Cytori Cell Therapy

Novel stem cell therapy demonstrates preclinical efficacy in AD models

FDA grants breakthrough therapy designation for venetoclax in relapsed/refractory CLL

FDA approves Neulasta to treat radiation sickness

Launch of a new partnership focused on accelerating Alzheimer's treatment

Apatorsen misses PFS endpoint in phase II NSCLC trial

Sunshine Lake Pharma patents 5-HT6 receptor antagonists

Ensysce Biosciences and Signature Therapeutics complete merger

Spero Therapeutics describes antibacterials

Daiichi Sankyo develops LRS inhibitors

The University of Tokyo divulges P2Y10 agonists

Kuros Biosurgery Holding closes merger with Cytos Biotechnology

UAB Research Foundation reports retinoid RXR agonists

Cosentyx available in U.S. for treatment of ankylosing spondylitis and psoriatic arthritis

New sound wave technology may revolutionize nebulizers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...